Search
for
Sort by
Research 91–120 of 526
- Management of folliculitis decalvans: The EADV task force on hair diseases position statement
- Retrospective analysis of smell and taste disturbances associated with dermatologic medications reported to the United States Food and Drug Administration and relevance to COVID-19 infections
- Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy
- From Misdiagnosis to Targeted Therapy: A Case Report of Folliculitis Decalvans and Lichen Planopilaris Phenotypic Spectrum
- 0557 Possible Contributory and Protective Factors in Medication Associated Obstructive Sleep Apnea (OSA): Results from the US Food and Drug Administration (FDA) Adverse Events Reporting System (FAERS)
- Medications
- Dermoscopy of an osteonevus of Nanta
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Lifting the biofilm lid on the antibacterial and antibiofilm effects of sodium hypochlorite against <i>Staphylococcus aureus</i> in atopic dermatitis
- Salivary Gland Inflammation During Acitretin Therapy for Generalized Pustular Psoriasis: a Case Report and Diagnostic Challenge
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- Dermoscopic evaluation of therapeutic response to an intralesional corticosteroid in the treatment of alopecia areata
- Medication-Induced Repigmentation of Gray Hair: A Systematic Review
- Guidelines for the Use of Acitretin in Psoriasis
- Analyzing the Efficacy of Isotretinoin in Treating Dissecting Cellulitis: A Literature Review and Meta-Analysis
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Alopecia Areata After Initiation of Secukinumab Therapy for Plaque Psoriasis
- Psoriatic onychopachydermoperiostitis: improvement with etanercept
- Adipose tissue transplant in recurrent folliculitis decalvans
- Successful Management of Folliculitis Decalvans
- Development of squamous cell carcinoma from erythroplasia of Queyrat following photodynamic therapy
- Immune-Mediated Skin Reactions Induced by Recombinant Antibodies and Other TNF-Alpha Inhibitors
- Cytokine-targeted treatment in alopecia areata - new possibilities?
- Telogen effl uvium as the fi rst symptom of Crohn's disease in a child
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- DERMATOLOGICAL CONDITIONS IN TRANSGENDER PATIENTS: A SYSTEMATIC REVIEW
- Tratamento da foliculite decalvante com laser de Erbium-YAG
- Plaque Psoriasis Formation and Body Hair (Re)Growth: A Common Pathway Activation?
- Subject Index
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment